Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / MIPLYFFA
Other

MIPLYFFA

Tracked across 1 events · 6 articles · First seen Jun 08, 2026 · Last active Jun 08, 2026

Sentiment
50
Attention
3
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
3 50
Regulatory
Zevra Therapeutics Extends MIPLYFFA Patent
Impact: MIPLYFFA is a therapeutic option for Niemann-Pick disease type C, and its patent protection has been extended until 2041, enhancing its market value.
Jun 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track MIPLYFFA live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.